Accredited Continuing Education
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Interventional Cardiology Program and Congenital Heart Disease Program Credit Designation
SCAI designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses
Nurses, including Registered Nurses (RNs) and Nurse Practitioners (NPs), can receive and use AMA PRA Category 1 CreditTM to fulfill Nursing CPD and recertification requirements with most certifying bodies and state licensure boards. Please check with your state for specific requirements.
Radiologic Technicians
This education activity is pending approval by the Association for Vascular and Interventional Radiographers (AVIR) for up to 4 A+ credit hours.
Successful Completion
Check into the conference onsite and pick up your badge. This creates an attendance record. Participate in the program. Then, complete the post-activity evaluation to claim credit.
Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from Medtronic. Additionally, Medtronic is providing medical devices as temporary in-kind support.
Disclosures
Individuals in control of content disclosed the following relevant relationships with ineligible companies during the content development process for this activity.
Program Chairs
- Angela Brown: Medtronic, advisory board. Recor Medical, speaker.
- Tai Kobayashi: Boston Scientific Corp, advisory board. Medtronic, advisory board. Recor Medical, advisory board.
Reviewer
Nkechi Ijioma has no financial relationships with ineligible companies.
Staff
Laura Porter has no financial relationships with ineligible companies.
Faculty Disclosures
Faculty disclosures will be posted once available.
Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
Planning Process
The RDN Regional Program, St. Louis agenda was developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. The agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.
All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.
Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.